HISA 2027 Budget Tests Horse Racing Regulation Costs
The HISA 2027 budget arrives at an uncomfortable point in American Thoroughbred racing’s regulatory experiment. The proposed spending plan is smaller than last year’s, yet the argument over what national safety and anti-doping oversight costs—and who ultimately carries that cost—has not become any simpler.
That tension matters because horse safety, medication control and economic sustainability cannot be separated indefinitely. Uniform regulation has created a national structure where racing once relied heavily on state-by-state systems, but a national system also has fixed costs that do not disappear every time the number of covered starts declines. Recent racing integrity questions have already shown how quickly confidence in enforcement can become part of racing’s larger credibility debate on Heritage Sports betting app reviews.
HISA 2027 Budget Is A Cost Test As Much As A Safety Test
The Federal Trade Commission has opened the proposed budget for public review, with comments due September 24. The Commission will then determine whether the plan satisfies the Horseracing Integrity and Safety Act’s standard of being prudent, cost-effective and sufficiently funded. The current public comment window gives industry participants a direct opportunity to address individual line items or the larger cost structure.
HISA’s proposed gross budget is roughly 5.75% lower than the 2026 budget, a reduction exceeding $4.4 million. Since 2025, the gross budget has fallen about 9.5%.
Those numbers support HISA’s case that costs are moving downward.
But regulatory affordability is not determined only by whether the total budget falls. It also depends on how many racetracks and starts remain available to absorb expenses.
That is where the harder economic question begins.
Anti-Doping Still Consumes Most Of The Regulatory Dollar
The largest spending concentration is not administration or racetrack accreditation. It is anti-doping, laboratory testing and adjudication.
HIWU, laboratory testing and adjudication together account for approximately $53.57 million, more than 72% of the proposed gross budget. HIWU itself is budgeted at about $35.29 million, roughly 5.2% below its 2026 allocation.
The full federal budget filing shows why those costs remain substantial. The program includes testing strategy, sample collection, laboratory accreditation, investigations, results management, case adjudication, education, technology and enforcement. In 2025, HIWU oversaw more than 111,000 blood, urine and hair sample collections.
That scale complicates simple claims that regulation is either obviously too expensive or obviously inexpensive.
The system is doing more than purchasing laboratory tests. It is funding an enforcement infrastructure.
The question is whether regulatory output matches cost closely enough to sustain industry confidence.
A Smaller Budget Can Still Produce Assessment Pressure
This is the part of the debate most likely to be misunderstood.
HISA can cut its overall budget while individual tracks still experience financial pressure because the assessment base is also changing.
Texas racetracks and Hawthorne are not included in the 2027 proposed assessment structure. Louisiana and West Virginia also remain outside the system under an existing preliminary injunction. HISA states that nationwide starts used for calculating the proposed budget declined 8.56% compared with the starts used for 2026, with nearly 60% of that decline tied to removing Texas tracks and Hawthorne.
Fewer starts matter because a significant portion of HISA’s expenses are fixed or do not move proportionally with racing volume.
A national technology platform still has to operate. Investigative capability still has to exist. Laboratory oversight, accreditation and administrative infrastructure remain necessary even if the covered universe becomes smaller.
That creates a scale problem: lower total spending does not guarantee lower cost per start.
The key numbers show why the debate has several layers:
| 2027 Budget Signal | Proposed Figure | Regulatory Meaning |
|---|---|---|
| Gross budget change | Down about 5.75% | HISA is proposing lower overall spending |
| HIWU, labs and adjudication | About $53.57M | Enforcement remains the dominant expense |
| Share of gross budget | More than 72% | Anti-doping drives most regulatory costs |
| Expected credits | About $16.24M | Some state and track services offset gross assessments |
| Nationwide starts used | Down 8.56% | Fewer starts can increase cost pressure per start |
| HIWU budget | About $35.29M | Enforcement spending is also being reduced |
The comparison shows why both sides of the cost discussion can point to real numbers. Spending is falling, but the base supporting that spending is also shrinking.
Credits Make The Headline Budget Less Simple Than It Looks
Gross budget figures are useful, but they are not identical to what the industry ultimately pays.
HISA expects roughly $16.24 million in credits for services that states or racetracks provide directly, including functions such as sample collection and some laboratory work. Those credits are deducted from the gross assessments of eligible jurisdictions rather than treated as a simple across-the-board reduction.
That distinction is important.
A track receiving significant credit may experience the regulatory cost differently from one performing fewer reimbursable functions. The result is a funding system where two operators can look at the same national budget and reach very different conclusions about affordability.
HISA’s own proposed-budget process began with an industry comment period in July before the final proposal moved to the FTC. The Authority says reducing costs remains part of its operating strategy.
Critics, meanwhile, have focused on per-start assessments and whether falling racing volume is concentrating too much expense among remaining participants.
Both issues can exist simultaneously.
Safety Outcomes Belong In The Cost Conversation
There is a danger in treating this entirely like an accounting exercise.
Racing regulation exists because medication control, track safety, injury prevention, laboratory integrity and consistent enforcement affect horses, participants and the sport’s credibility.
The proposed budget adds or maintains spending in areas including epidemiological analysis, research into exercise-associated sudden death and national safety-data work. HISA also points to declining equine fatality rates as evidence that its safety framework is producing measurable results.
That does not settle the cost argument.
A safety program can produce valuable outcomes and still face legitimate questions about efficiency. Likewise, a lower budget does not automatically demonstrate that every expenditure is optimized.
The useful standard is cost against measurable results.
Testing volume, case-resolution times, injury trends, fatality rates, laboratory performance and enforcement consistency give the industry better tools for judging the system than either broad support or broad opposition to HISA.
The FTC Deadline Puts The Next Decision In Focus
September 24 is therefore more than an administrative deadline.
The FTC is reviewing whether the budget meets the statutory standards for cost effectiveness and adequate funding, and it can approve, disapprove or modify the proposed plan. That puts the financial architecture of national Thoroughbred regulation back under formal scrutiny.
The next signals will be the quality of public comments, any modifications that emerge from FTC review, the final assessment structure and whether additional racing jurisdictions eventually enter or re-enter HISA’s system.
Greater participation could spread fixed expenses across more starts. Continued contraction would keep the opposite pressure alive.
That is why the HISA 2027 budget matters beyond a single annual spending plan. Racing is testing whether a national regulatory structure can simultaneously deliver credible safety and anti-doping enforcement, reduce its operating costs and remain affordable for the tracks and horsemen financing it.
The numbers show progress on one side of that equation: the proposed budget is smaller. The unresolved question is whether the system can become cheaper per participant without weakening the safety and integrity functions it was created to provide.